Analyst Price Target is $1,850.00
▲ +8,760.15% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Smiths Group in the last 3 months. The average price target is $1,850.00, with a high forecast of $2,040.00 and a low forecast of $1,650.00. The average price target represents a 8,760.15% upside from the last price of $20.88.
Current Consensus is
Hold
The current consensus among 4 polled investment analysts is to hold stock in Smiths Group. This rating has held steady since September 2022, when it changed from a Buy consensus rating.
Smiths Group Plc engages in the development, manufacture, and sale of control systems and instruments for industrial applications. It operates through the following business segments: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, and Flex-Tek. The John Crane segment produces mechanical seals, engineered bearings, power transmission couplings, seal support, and filtration systems. The Smiths Medical segment develops and markets infusions systems, patient airway and temperature management equipment, and devices for in vitro fertilization, diagnostics, and emergency patient transport. The Smiths Detection segment manufactures sensors that detect explosives, narcotics, weapons, chemical agents, biohazards, and contraband. The Smiths Interconnect segment offers electronic and radio frequency components and sub-systems. The Flex-Trek segment includes components that heat and move fluids and gases, flexible hosing and rigid tubing. The company was founded by Samuel Smith in 1851 and is headquartered in London, the United Kingdom.
Read More
